178
Bensussan A, Gluckman E, el Marsafy S et al (1994) BY55 monoclonal antibody delineates within
human cord blood and bone marrow lymphocytes distinct cell subsets mediating cytotoxic
activity. Proc Natl Acad Sci U S A 91:9136–9140. doi: 10.1073/pnas.91.19.9136
Berthou C, Legros-Maïda S, Soulié A et al (1995) Cord blood T lymphocytes lack constitutive
perforin expression in contrast to adult peripheral blood T lymphocytes. Blood 85:1540–1546
Brown N, Machin L, McLeod D (2011) Immunitary bioeconomy: the economisation of life in the
international cord blood market. Soc Sci Med 72:1115–1122
Broxmeyer HE, Douglas GW, Hangoc G et al (1989) Human umbilical cord blood as a potential
source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci U S A
86:3828–3832
Butler MG, Menitove JE (2011) Umbilical cord blood banking: an update. J Assist Reprod Genet
28:669–676
Eapen M, Rubinstein P, Zhang M-J et al (2007) Outcomes of transplantation of unrelated donor
umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study.
Lancet 369:1947–1954
Eapen M, Klein JP, Sanz GF et al (2011) Effect of donor-recipient HLA matching at HLA A, B, C,
and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelo-
dysplastic syndrome: a retrospective analysis. Lancet Oncol 12:1214–1221
Eapen M, Klein JP, Ruggeri A et al (2014) Impact of allele-level HLA matching on outcomes after
myeloablative single unit umbilical cord blood transplantation for hematologic malignancy.
Blood 123:133–140
Ecker JL, Greene MF (2005) The case against private umbilical cord banking. Obstet Gynecol
105:1282–1284
Faulkner B, Uderzo C, Masera G (2013) International cooperation for the cure and prevention of
severe hemoglobinopathies. J Pediatr Hematol Oncol 35:419–423
Geissler M, Dinse HR, Neuhoff S et al (2011) Human umbilical cord blood cells restore brain
damage induced changes in rat somatosensory cortex. PLoS One 6:e20194
Giannopoulou EZ, Puff R, Beyerlein A et al (2014) Effect of a single autologous cord blood infu-
sion on beta-cell and immune function in children with new onset type 1 diabetes: a non-
randomized, controlled trial. Pediatr Diabetes 15:100–109
Gluckman E, Broxmeyer HA, Auerbach AD et al (1989) Hematopoietic reconstitution in a patient
with Fanconi’s anemia by means of umbilical-cord blood from an HLA-identical sibling. N
Engl J Med 321:1174–1178
Gluckman E, Rocha V, Boyer-Chammard A et al (1997) Outcome of cord-blood transplantation
from related and unrelated donors. Eurocord Transplant Group and the European Blood and
Marrow Transplantation Group. N Engl J Med 337:373–381
Gragert L, Eapen M, Williams E et al (2014) HLA match likelihoods for hematopoietic stem-cell
grafts in the U.S. registry. N Engl J Med 371:339–348
Guilcher GMT, Fernandez CV, Joffe S (2014) Are hybrid umbilical cord blood banks really the
best of both worlds? J Med Ethics 1–4. doi: 10.1136/medethics-2013-101673
Haller MJ, Wasserfall CH, Hulme MA et al (2011) Autologous umbilical cord blood transfusion in
young children with type 1 diabetes fails to preserve C-peptide. Diabetes Care 34:2567–2569
Harris DT, Schumacher MJ, Locascio J et al (1992) Phenotypic and functional immaturity of
human umbilical cord blood T lymphocytes. Proc Natl Acad Sci U S A 89:10006–10010
Hildbrand P, Cirulli V, Prinsen RC et al (2004) The role of angiopoietins in the development of
endothelial cells from cord blood CD34+ progenitors. Blood 104:2010–2019
Hollands P, McCauley C (2009) Private cord blood banking: current use and clinical future. Stem
Cell Rev Rep 5:195–203
Iafolla MA, Tay J, Allan DS (2014) Transplantation of umbilical cord blood-derived cells for novel
indications in regenerative therapy or immune modulation: a scoping review of clinical studies.
Biol Blood Marrow Transplant 20:20–25
Jordaan DW, Woodrow C, Pepper MS (2009) Banning private umbilical cord blood banks: a
human rights analysis. S Afr J Hum Rights 25:126–151
H.C. Steel et al.